← Eichor
Study identifier: NCT05853718 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Study of Tenofovir Alafenamide in HBV-Infected Pregnant Women

Condition: Chronic Hepatitis b · Tenofovir Alafenamide Fumarate  ·  Sponsor: First People's Hospital of Hangzhou

PhasePhase 4
Planned participants50
Who can joinFemale, 20 Years to 40 Years
Healthy volunteersNo

About this study

The purpose of this study is to evaluate the pharmacokinetics, efficacy and safety of TAF in HBV-infected pregnant women.

This description comes directly from the study's public registry record.

Talk to the study team

Jie Jin, MD  ·  13372517879  ·  jinjie0429@163.com

Zhiyuan Ma, PhD  ·  18858273870  ·  zhiyuan_ma@zju.edu.cn

Always discuss trial participation with your own doctor first.

Locations (1)

Hangzhou First People's HospitalHangzhou, Zhejiang, ChinaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05853718